{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T11:08:17Z","timestamp":1747998497501,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2014\u2013 2271"],"award-info":[{"award-number":["2014\u2013 2271"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["2013\/469"],"award-info":[{"award-number":["2013\/469"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"M\u00e4rit and Hans Rausing Initiative Against Breast Cancer"},{"name":"Cancer and Risk Prediction Center"},{"name":"Linneus Centre","award":["70867902"],"award-info":[{"award-number":["70867902"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13058-018-1026-7","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T13:07:11Z","timestamp":1533820031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-8893","authenticated-orcid":false,"given":"Signe","family":"Borgquist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann H.","family":"Rosendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamila","family":"Czene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmala","family":"Bhoo-Pathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozhgan","family":"Dorkhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith S.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"issue":"7","key":"1026_CR1","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674\u201385.","journal-title":"Diabetes Care"},{"issue":"41","key":"1026_CR2","doi-asserted-by":"crossref","first-page":"38023","DOI":"10.1074\/jbc.M104416200","volume":"276","author":"J Chappell","year":"2001","unstructured":"Chappell J, Leitner JW, Solomon S, Golovchenko I, Goalstone ML, Draznin B. Effect of insulin on cell cycle progression in MCF-7 breast cancer cells: direct and potentiating influence. J Biol Chem. 2001;276(41):38023\u20138.","journal-title":"J Biol Chem"},{"issue":"Suppl 2","key":"1026_CR3","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1007\/s001250051393","volume":"40","author":"D Ish-Shalom","year":"1997","unstructured":"Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, De Meyts P. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia. 1997;40(Suppl 2):S25\u201331.","journal-title":"Diabetologia"},{"issue":"6","key":"1026_CR4","doi-asserted-by":"publisher","first-page":"R225","DOI":"10.1530\/ERC-12-0203","volume":"19","author":"DP Rose","year":"2012","unstructured":"Rose DP, Vona-Davis L. The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr Relat Cancer. 2012;19(6):R225\u201341.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1026_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/dc15-1816","volume":"39","author":"JW Wu","year":"2016","unstructured":"Wu JW, Filion KB, Azoulay L, Doll MK, Suissa S. Effect of long-acting insulin analogs on the risk of cancer: a systematic review of observational studies. Diabetes Care. 2016;39(3):486\u201394.","journal-title":"Diabetes Care"},{"key":"1026_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13058-015-0611-2","volume":"17","author":"HK Bronsveld","year":"2015","unstructured":"Bronsveld HK, ter Braak B, Karlstad O, Vestergaard P, Starup-Linde J, Bazelier MT, De Bruin ML, de Boer A, Siezen CL, van de Water B, et al. Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Res. 2015;17:100.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"1026_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1463-1326.2012.01614.x","volume":"14","author":"V Formica","year":"2012","unstructured":"Formica V, Tesauro M, Cardillo C, Roselli M. Insulinemia and the risk of breast cancer and its relapse. Diabetes Obes Metab. 2012;14(12):1073\u201380.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"1026_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/13813450801954451","volume":"114","author":"P Pisani","year":"2008","unstructured":"Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem. 2008;114(1):63\u201370.","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"1026_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ijc.22717","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856\u201362.","journal-title":"Int J Cancer"},{"issue":"5","key":"1026_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2337\/dc13-1468","volume":"37","author":"L Bordeleau","year":"2014","unstructured":"Bordeleau L, Yakubovich N, Dagenais GR, Rosenstock J, Probstfield J, Chang Yu P, Ryden LE, Pirags V, Spinas GA, Birkeland KI, et al. The association of basal insulin glargine and\/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care. 2014;37(5):1360\u20136.","journal-title":"Diabetes Care"},{"issue":"9","key":"1026_CR11","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00125-009-1452-2","volume":"52","author":"J Rosenstock","year":"2009","unstructured":"Rosenstock J, Fonseca V, McGill JB, Riddle M, Halle JP, Hramiak I, Johnston P, Davis M. Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia. 2009;52(9):1971\u20133.","journal-title":"Diabetologia"},{"issue":"11","key":"1026_CR12","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.2337\/dc13-0263","volume":"36","author":"T Sturmer","year":"2013","unstructured":"Sturmer T, Marquis MA, Zhou H, Meigs JB, Lim S, Blonde L, Macdonald E, Wang R, Lavange LM, Pate V, et al. Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin. Diabetes Care. 2013;36(11):3517\u201325.","journal-title":"Diabetes Care"},{"issue":"9","key":"1026_CR13","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00125-011-2190-9","volume":"54","author":"S Suissa","year":"2011","unstructured":"Suissa S, Azoulay L, Dell\u2019Aniello S, Evans M, Vora J, Pollak M. Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia. 2011;54(9):2254\u201362.","journal-title":"Diabetologia"},{"issue":"32","key":"1026_CR14","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1200\/JCO.2017.73.4491","volume":"35","author":"JW Wu","year":"2017","unstructured":"Wu JW, Azoulay L, Majdan A, Boivin JF, Pollak M, Suissa S. Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes. J Clin Oncol. 2017;35(32):3647\u201353.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1026_CR15","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, Trub T. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 2000;49(6):999\u20131005.","journal-title":"Diabetes"},{"issue":"12","key":"1026_CR16","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00125-010-1899-1","volume":"53","author":"E Yehezkel","year":"2010","unstructured":"Yehezkel E, Weinstein D, Simon M, Sarfstein R, Laron Z, Werner H. Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia. 2010;53(12):2667\u201375.","journal-title":"Diabetologia"},{"issue":"1","key":"1026_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/jnci\/djn415","volume":"101","author":"MJ Gunter","year":"2009","unstructured":"Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101(1):48\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1026_CR18","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/ijc.24609","volume":"125","author":"GC Kabat","year":"2009","unstructured":"Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ, et al. Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer. 2009;125(11):2704\u201310.","journal-title":"Int J Cancer"},{"issue":"3","key":"1026_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/B:CACO.0000024225.14618.a8","volume":"15","author":"DA Lawlor","year":"2004","unstructured":"Lawlor DA, Smith GD, Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women\u2019s Heart and Health study. Cancer Causes Control. 2004;15(3):267\u201375.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"1026_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/aje\/kwf050","volume":"156","author":"PJ Mink","year":"2002","unstructured":"Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR. Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol. 2002;156(4):349\u201352.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1026_CR21","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","volume":"15","author":"VA McCormack","year":"2006","unstructured":"McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159\u201369.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"1026_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-016-4090-7","volume":"162","author":"JO Wanders","year":"2017","unstructured":"Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N. Volumetric breast density affects performance of digital screening mammography. Breast Cancer Res Treat. 2017;162(1):95\u2013103.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"1026_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","volume":"6","author":"NF Boyd","year":"2005","unstructured":"Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798\u2013808.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1026_CR24","doi-asserted-by":"publisher","first-page":"djv178","DOI":"10.1093\/jnci\/djv178","volume":"107","author":"KT Nead","year":"2015","unstructured":"Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A, Australian National Endometrial Cancer Study Group (ANECS), Perry JR, Attia J, et al. Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis. J Natl Cancer Inst. 2015;107(9):djv178.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1026_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/ije\/dyw357","volume":"46","author":"M Gabrielson","year":"2017","unstructured":"Gabrielson M, Eriksson M, Hammarstr\u00f6m M, Borgquist S, Leifland K, Czene K, Hall P. Cohort profile: the Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). Int J Epidemiol. 2017;46(6):1740\u20131g.","journal-title":"Int J Epidemiol"},{"key":"1026_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"7","key":"1026_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M. The new Swedish prescribed drug register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"23","key":"1026_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/jnci\/djg105","volume":"95","author":"K Zendehdel","year":"2003","unstructured":"Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst. 2003;95(23):1797\u2013800.","journal-title":"J Natl Cancer Inst"},{"key":"1026_CR29","doi-asserted-by":"publisher","first-page":"13871","DOI":"10.1038\/srep13871","volume":"5","author":"K Hemminki","year":"2015","unstructured":"Hemminki K, Liu X, Forsti A, Sundquist J, Sundquist K, Ji J. Subsequent type 2 diabetes in patients with autoimmune disease. Sci Rep. 2015;5:13871.","journal-title":"Sci Rep"},{"issue":"9","key":"1026_CR30","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1158\/1055-9965.EPI-13-1219","volume":"23","author":"JS Brand","year":"2014","unstructured":"Brand JS, Czene K, Shepherd JA, Leifland K, Heddson B, Sundbom A, Eriksson M, Li J, Humphreys K, Hall P. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment. Cancer Epidemiol Biomark Prev. 2014;23(9):1764\u201372.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1026_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/978-3-642-13666-5_46","volume":"6136","author":"R Highnam","year":"2010","unstructured":"Highnam R, Brady M, Yaffe MJ, Karssemeijer N, Harvey J. Robust breast composition measurement - VolparaTM. Lect Notes Comput Sci. 2010;6136:342\u20139.","journal-title":"Lect Notes Comput Sci"},{"issue":"5","key":"1026_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13058-014-0439-1","volume":"16","author":"A Eng","year":"2014","unstructured":"Eng A, Gallant Z, Shepherd J, McCormack V, Li J, Dowsett M, Vinnicombe S, Allen S, dos -Santos-Silva I. Digital mammographic density and breast cancer risk: a case-control study of six alternative density assessment methods. Breast Cancer Res. 2014;16(5):439.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"1026_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"4","key":"1026_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ng.2563","volume":"45","author":"K Michailidou","year":"2013","unstructured":"Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353\u201361. e2","journal-title":"Nat Genet"},{"issue":"1","key":"1026_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/1055-9965.EPI-16-0106","volume":"26","author":"CI Amos","year":"2017","unstructured":"Amos CI, Dennis J, Wang Z, Byun J, Schumacher FR, Gayther SA, Casey G, Hunter DJ, Sellers TA, Gruber SB, et al. The OncoArray Consortium: a network for understanding the genetic architecture of common cancers. Cancer Epidemiol Biomark Prev. 2017;26(1):126\u201335.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"1026_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","volume":"44","author":"RA Scott","year":"2012","unstructured":"Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Magi R, Strawbridge RJ, Rehnberg E, Gustafsson S, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44(9):991\u20131005.","journal-title":"Nat Genet"},{"key":"1026_CR37","doi-asserted-by":"publisher","first-page":"j3683","DOI":"10.1136\/bmj.j3683","volume":"358","author":"TJ Cole","year":"2017","unstructured":"Cole TJ, Altman DG. Statistics notes: percentage differences, symmetry, and natural logarithms. BMJ. 2017;358:j3683.","journal-title":"BMJ"},{"key":"1026_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"issue":"4","key":"1026_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377\u201399.","journal-title":"Stat Med"},{"issue":"6","key":"1026_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/bcr2942","volume":"13","author":"NF Boyd","year":"2011","unstructured":"Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res. 2011;13(6):223.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1026_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10552-016-0829-z","volume":"28","author":"K Buschard","year":"2017","unstructured":"Buschard K, Thomassen K, Lynge E, Vejborg I, Tjonneland A, von Euler-Chelpin M, Andersen ZJ. Diabetes, diabetes treatment, and mammographic density in Danish diet, Cancer, and Health cohort. Cancer Causes Control. 2017;28(1):13\u201321.","journal-title":"Cancer Causes Control"},{"issue":"8","key":"1026_CR42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/dc09-0479","volume":"32","author":"R Jimenez-Garcia","year":"2009","unstructured":"Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Gil A. Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care. 2009;32(8):1470\u20132.","journal-title":"Diabetes Care"},{"issue":"18","key":"1026_CR43","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1001\/archinte.165.18.2090","volume":"165","author":"LL Lipscombe","year":"2005","unstructured":"Lipscombe LL, Hux JE, Booth GL. Reduced screening mammography among women with diabetes. Arch Intern Med. 2005;165(18):2090\u20135.","journal-title":"Arch Intern Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-018-1026-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-018-1026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T23:53:29Z","timestamp":1661730809000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-018-1026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1186\/s13058-018-1026-7","relation":{},"ISSN":["1465-542X"],"issn-type":[{"type":"electronic","value":"1465-542X"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"27 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants signed informed consent forms, and the ethical review board at Karolinska Institutet approved the study (2010\/958-31\/1).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the manuscript and consented to its publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MD declares being employed by Novo Nordisk (Denmark). All other authors declare that they have no competing interests. Novo Nordisk had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"93"}}